SEC Form 4 · accession 0000891293-15-000037

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Corporate Development

Period of report

Sep 24, 2015

Accepted (ET)

Sep 25, 2015 · 4:42 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Sep 24, 2015	S	3,600	$1.52	D	797,353	D
Common Stock	Sep 24, 2015	S	13,201	$1.525	D	784,152	D
Common Stock	Sep 24, 2015	S	200	$1.5275	D	783,952	D
Common Stock	Sep 24, 2015	S	6,899	$1.53	D	777,053	D
Common Stock	Sep 24, 2015	S	100	$1.535	D	776,953	D
Common Stock	Sep 24, 2015	S	289	$1.54	D	776,664	D
Common Stock	Sep 24, 2015	S	600	$1.545	D	776,064	D
Common Stock	Sep 24, 2015	S	800	$1.55	D	775,264	D
Common Stock	Sep 24, 2015	S	800	$1.56	D	774,464	D
Common Stock	Sep 24, 2015	S	1,700	$1.57	D	772,764	D
Common Stock	Sep 24, 2015	S	1,000	$1.575	D	771,764	D
Common Stock	Sep 24, 2015	S	5,330	$1.58	D	766,434	D
Common Stock	Sep 24, 2015	S	7,000	$1.585	D	759,434	D
Common Stock	Sep 24, 2015	S	16,400	$1.59	D	743,034	D
Common Stock	Sep 24, 2015	S	1,500	$1.595	D	741,534	D
Common Stock	Sep 24, 2015	S	14,400	$1.60	D	727,134	D
Common Stock	Sep 24, 2015	S	1,390	$1.605	D	725,744	D
Common Stock	Sep 24, 2015	S	660	$1.61	D	725,084	D

No Table II lines on this filing.